Analysis of the ROC curve for MFAP4 showed an area under the ROC curve (AUC) of 0.833, indicating that MFAP4 was able to accurately differentiate between tumor and normal control samples, and that its expression in gliomas has a high diagnostic value (Figure 3A). Here, MFAP4 is linked to central nervous system cancer.